Valuation Guardant Health, Inc.

Equities

Market Closed - Nasdaq Other stock markets 21:00:00 13/02/2026 GMT			5-day change	1st Jan Change
104.85 ^USD	+2.03%		-0.47%	+2.65%

02-02	Guardant Health, Inc. Announces Publication of the Largest Study to Date Evaluating Circulating Tumors forMRD Detection in Patients with Rescted Stage III Colon Cancer After Surgery and Before Adjuvant Chemotherapy	CI
01-30	UBS Adjusts Price Target on Guardant Health to $175 From $110, Maintains Buy Rating	MT

Data adjusted to current consolidation scope

Fiscal Period: December	2020	2021	2022	2023	2024	2025	2026	2027
Capitalization ¹	12,884	10,168	2,786	3,283	3,775	13,509	13,509	-
Change	-	-21.09%	-72.6%	17.84%	14.96%	257.89%	0%	-
Enterprise Value (EV) ¹	11,896	10,370	2,912	3,255	4,077	14,111	14,433	13,890
Change	-	-12.83%	-71.91%	11.75%	25.27%	246.1%	2.28%	-3.76%
P/E ratio	-49.6x	-25x	-4.24x	-6.32x	-8.58x	-34x	-37.9x	-56.9x
PBR	9.95x	15.8x	46.4x	20.7x	-27.1x	-32.7x	-26x	-50x
PEG	-	-0.5x	-0.1x	0.2x	0.5x	2.6x	3.7x	1.7x
Capitalization / Revenue	44.9x	27.2x	6.2x	5.82x	5.11x	13.9x	10.9x	8.53x
EV / Revenue	41.5x	27.8x	6.48x	5.77x	5.52x	14.5x	11.6x	8.77x
EV / EBITDA	-140x	-26.7x	-5.84x	-7.46x	-10.2x	-65.3x	-97.8x	355x
EV / EBIT	-46.7x	-25.2x	-5.35x	-5.76x	-9.19x	-36.1x	-41.1x	-54.8x
EV / FCF	-	-	-	-	-	-	-62,209,416x	-98,513,071x
FCF Yield	-	-	-	-	-	-	-0%	-0%
Dividend per Share ²	-	-	-	-	-	-	-	-
Rate of return	-	-	-	-	-	-	-	-
EPS ²	-2.6	-4	-6.41	-4.28	-3.56	-3.087	-2.767	-1.842
Distribution rate	-	-	-	-	-	-	-	-
Net sales ¹	286.7	373.7	449.5	563.9	739	972	1,241	1,584
EBITDA ¹	-85.18	-388.7	-498.9	-436.3	-399.5	-216.1	-147.5	39.15
EBIT ¹	-255	-411	-544.4	-564.7	-443.6	-391.4	-350.8	-253.7
Net income ¹	-253.8	-405.7	-654.6	-479.4	-436.4	-384.8	-347.5	-224.8
Net Debt ¹	-988.6	202.1	126.2	-28.67	302.6	602.3	923.8	381.6
Reference price ²	128.88	100.02	27.20	27.05	30.55	104.85	104.85	104.85
Nbr of stocks (in thousands)	99,972	101,656	102,436	121,380	123,555	128,839	128,839	-
Announcement Date	24/02/21	23/02/22	23/02/23	22/02/24	20/02/25	-	-	-

¹USD in Million²USD

Estimates

Add to a list 0 selected To use this feature you must be a member Log in Sign up	P/E (Y)	EV / Sales (Y)	EV / EBITDA (Y)	Dividend Yield (Y)	Capi.($)
GUARDANT HEALTH, INC.	-33.97x	14.52x	-65.3x	-.--%	13.51B
BIOMÉRIEUX	24.07x	2.59x	10.42x	0.98%	13B
SHENZHEN NEW INDUSTRIES BIOMEDICAL ENGINEERING CO., LTD.	24.3x	8.43x	19.39x	2.3%	5.92B
CARIS LIFE SCIENCES, INC.	-17.04x	6.7x	68.64x	-	5.82B
DIASORIN S.P.A.	21.89x	3.75x	11.36x	1.66%	4.73B
LANTHEUS HOLDINGS, INC.	22.03x	3.19x	8.66x	-	4.6B
AUTOBIO DIAGNOSTICS CO., LTD.	17.7x	-	-	3.43%	2.99B
10X GENOMICS, INC.	-18.42x	3.02x	-20.23x	-.--%	2.31B
Average	5.07x	6.03x	4.70x	1.39%	6.61B
Weighted average by Cap.	2.16x	7.18x	-3.72x	1.05%